Sujata M. Bhavnani, PharmD; MS; FIDSA
Executive Vice President
Institute for Clinical Pharmacodynamics
Schenectady, NY, United States
Disclosure: Disclosure(s): Adagio Therapeutics, Inc.: Grant/Research Support (); Amplyx Pharmaceuticals, Inc.: Grant/Research Support (); AN2 Therapeutics: Grant/Research Support (); Antabio SAS: Grant/Research Support (); Arcutis Biotherapeutics, Inc.: Grant/Research Support (); B. Braun Medical Inc.: Grant/Research Support (); Basilea Pharmaceutica: Grant/Research Support (); Boston Pharmaceuticals: Grant/Research Support (); Bravos Biosciences: Ownership Interest (); Celdara Medical LLC: Grant/Research Support (); Cidara Therapeutics Inc.: Grant/Research Support (); Cipla USA: Grant/Research Support (); Crestone Inc.: Grant/Research Support (); CXC: Grant/Research Support (); Debiopharm International SA: Grant/Research Support (); Entasis Therapeutics: Grant/Research Support (); Evopoint Biosciences Co.: Grant/Research Support (); Fedora Pharmaceuticals: Grant/Research Support (); GlaxoSmithKline: Grant/Research Support (); Hoffmann-La Roche: Grant/Research Support (); ICPD: Ownership Interest (); ICPD Biosciences, LLC.: Ownership Interest (); ICPD Holdings: Ownership Interest (); ICPD Technologies: Ownership Interest (); Insmed Inc.: Grant/Research Support (); Iterum Therapeutics Limited: Grant/Research Support (); Kaizen Bioscience, Co.: Grant/Research Support (); KBP Biosciences USA: Grant/Research Support (); Lassen Therapeutics: Grant/Research Support (); Matinas Biopharma: Grant/Research Support (); Meiji Seika Pharma Co., Ltd.: Grant/Research Support (); Menarini Ricerche S.p.A.: Grant/Research Support (); Mutabilis: Grant/Research Support (); Nabriva Therapeutics AG: Grant/Research Support (); Novartis Pharmaceuticals Corp.: Grant/Research Support (); Paratek Pharmaceuticals, Inc.: Grant/Research Support (); PureTech Health: Grant/Research Support (); Sfunga Therapeutics: Grant/Research Support (); Spero Therapeutics: Grant/Research Support (); Suzhou Sinovent Pharmaceuticals Co.: Grant/Research Support (); TauRx Therapeutics: Grant/Research Support (); Tetraphase Pharmaceuticals: Grant/Research Support (); tranScrip Partners: Grant/Research Support (); Utility Therapeutics: Grant/Research Support (); Valanbio Therapeutics, Inc.: Grant/Research Support (); VenatoRx: Grant/Research Support (); Wockhardt Bio AG: Grant/Research Support ()
Christopher M. Rubino, PharmD
Executive Vice President
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
Disclosure: Disclosure(s): Adagio Therapeutics: Grant/Research Support (); Amplyx Pharmaceuticals, Inc.: Grant/Research Support (); AN2 Therapeutics: Grant/Research Support (); Antabio SAS: Grant/Research Support (); Arcutis Biotherapeutics, Inc.: Grant/Research Support (); B. Braun Medical Inc.: Grant/Research Support (); Basilea Pharmaceutica: Grant/Research Support (); Boston Pharmaceuticals: Grant/Research Support (); Bravos Biosciences: Ownership Interest (); Celdara Medical LLC: Grant/Research Support (); Cidara Therapeutics Inc.: Grant/Research Support (); Cipla USA: Grant/Research Support (); Crestone Inc.: Grant/Research Support (); CXC: Grant/Research Support (); Debiopharm International SA: Grant/Research Support (); Entasis Therapeutics: Grant/Research Support (); Evopoint Biosciences Co.: Grant/Research Support (); Fedora Pharmaceuticals: Grant/Research Support (); GlaxoSmithKline: Grant/Research Support (); Hoffmann-La Roche: Grant/Research Support (); ICPD: Ownership Interest (); ICPD Biosciences, LLC.: Ownership Interest (); ICPD Holdings: Ownership Interest (); ICPD Technologies: Ownership Interest (); Insmed Inc.: Grant/Research Support (); Iterum Therapeutics Limited: Grant/Research Support (); Kaizen Bioscience, Co.: Grant/Research Support (); KBP Biosciences USA: Grant/Research Support (); Lassen Therapeutics: Grant/Research Support (); Matinas Biopharma: Grant/Research Support (); Meiji Seika Pharma Co., Ltd.: Grant/Research Support (); Melinta Therapeutics: Grant/Research Support (); Menarini Ricerche S.p.A.: Grant/Research Support (); Mutabilis: Grant/Research Support (); Nabriva Therapeutics AG: Grant/Research Support (); Novartis Pharmaceuticals Corp: Grant/Research Support (); Paratek Pharmaceuticals, Inc.: Grant/Research Support (); PureTech Health: Grant/Research Support (); Sfunga Therapeutics: Grant/Research Support (); Spero Therapeutics: Grant/Research Support (); Suzhou Sinovent Pharmaceuticals Co.: Grant/Research Support (); TauRx Therapeutics: Grant/Research Support (); Tetraphase Pharmaceuticals: Grant/Research Support (); tranScrip Partners: Grant/Research Support (); Utility Therapeutics: Grant/Research Support (); Valanbio Therapeutics, Inc.: Grant/Research Support (); VenatoRx: Grant/Research Support (); Wockhardt Bio AG: Grant/Research Support ()
Jeffrey P. Hammel, MS
Director
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
Disclosure: Disclosure(s): Adagio Therapeutics, Inc.: Grant/Research Support (); Amplyx Pharmaceuticals, Inc.: Grant/Research Support (); AN2 Therapeutics: Grant/Research Support (); Antabio SAS: Grant/Research Support (); Arcutis Biotherapeutics, Inc.: Grant/Research Support (); B. Braun Medical Inc.: Grant/Research Support (); Basilea Pharmaceutica: Grant/Research Support (); Boston Pharmaceuticals: Grant/Research Support (); Celdara Medical LLC: Grant/Research Support (); Cidara Therapeutics Inc.: Grant/Research Support (); Cipla USA: Grant/Research Support (); Crestone Inc.: Grant/Research Support (); CXC: Grant/Research Support (); Debiopharm International SA: Grant/Research Support (); Entasis Therapeutics: Grant/Research Support (); Evopoint Biosciences Co.: Grant/Research Support (); Fedora Pharmaceuticals: Grant/Research Support (); GlaxoSmithKline: Grant/Research Support (); Hoffmann-La Roche: Grant/Research Support (); Insmed Inc.: Grant/Research Support (); Iterum Therapeutics Limited: Grant/Research Support (); Kaizen Bioscience, Co.: Grant/Research Support (); KBP Biosciences USA: Grant/Research Support (); Lassen Therapeutics: Grant/Research Support (); Matinas Biopharma: Grant/Research Support (); Meiji Seika Pharma Co., Ltd.: Grant/Research Support (); Melinta Therapeutics: Grant/Research Support (); Menarini Ricerche S.p.A.: Grant/Research Support (); Mutabilis: Grant/Research Support (); Nabriva Therapeutics AG: Grant/Research Support (); Novartis Pharmaceuticals Corp.: Grant/Research Support (); Paratek Pharmaceuticals, Inc.: Grant/Research Support (); PureTech Health: Grant/Research Support (); Sfunga Therapeutics: Grant/Research Support (); Spero Therapeutics: Grant/Research Support (); Suzhou Sinovent Pharmaceuticals Co.: Grant/Research Support (); TauRx Therapeutics: Grant/Research Support (); Tetraphase Pharmaceuticals: Grant/Research Support (); tranScrip Partners: Grant/Research Support (); Utility Therapeutics: Grant/Research Support (); Valanbio Therapeutics, Inc.: Grant/Research Support (); VenatoRx: Grant/Research Support (); Wockhardt Bio AG: Grant/Research Support ()
Anthony P. Cammarata, M.S.
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
Disclosure: Disclosure(s): Adagio Therapeutics, Inc: Grant/Research Support (); Amplyx Pharmaceuticals, Inc.: Grant/Research Support (); AN2 Therapeutics: Grant/Research Support (); Antabio SAS: Grant/Research Support (); Arcutis Biotherapeutics, Inc: Grant/Research Support (); B. Braun Medical Inc.: Grant/Research Support (); Basilea Pharmaceutica: Grant/Research Support (); Boston Pharmaceuticals: Grant/Research Support (); Celdara Medical LLC: Grant/Research Support (); Cidara Therapeutics Inc: Grant/Research Support (); Cipla USA: Grant/Research Support (); Crestone Inc: Grant/Research Support (); CXC: Grant/Research Support (); Debiopharm International SA: Grant/Research Support (); Entasis Therapeutics: Grant/Research Support (); Evopoint Biosciences Co: Grant/Research Support (); Fedora Pharmaceuticals: Grant/Research Support (); GlaxoSmithKline: Grant/Research Support (); Hoffmann-La Roche: Grant/Research Support (); Insmed Inc.: Grant/Research Support (); Iterum Therapeutics Limited: Grant/Research Support (); Kaizen Bioscience, Co.: Grant/Research Support (); KBP Biosciences USA: Grant/Research Support (); Lassen Therapeutics: Grant/Research Support (); Matinas Biopharma: Grant/Research Support (); Meiji Seika Pharma Co., Ltd.: Grant/Research Support (); Melinta Therapeutics: Grant/Research Support (); Menarini Ricerche S.p.A.: Grant/Research Support (); Mutabilis: Grant/Research Support (); Nabriva Therapeutics AG: Grant/Research Support (); Novartis Pharmaceuticals Corp.: Grant/Research Support (); Paratek Pharmaceuticals, Inc.: Grant/Research Support (); PureTech Health: Grant/Research Support (); Sfunga Therapeutics: Grant/Research Support (); Spero Therapeutics: Grant/Research Support (); Suzhou Sinovent Pharmaceuticals Co.: Grant/Research Support (); TauRx Therapeutics: Grant/Research Support (); Tetraphase Pharmaceuticals: Grant/Research Support (); tranScrip Partners: Grant/Research Support (); Utility Therapeutics: Grant/Research Support (); Valanbio Therapeutics, Inc.: Grant/Research Support (); VenatoRx: Grant/Research Support (); Wockhardt Bio AG: Grant/Research Support ()
Kajal Larson, PhD
Director, Clinical Pharmacology
Entasis Therapeutics
Waltham, Massachusetts, United States
Disclosure: Disclosure(s): Entasis Therapeutics: Employee ()
Kathryn Liolios, MA
Statistician
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
Disclosure: Disclosure(s): Adagio Therapeutics, Inc.: Grant/Research Support (); Amplyx Pharmaceuticals, Inc.: Grant/Research Support (); AN2 Therapeutics: Grant/Research Support (); Antabio SAS: Grant/Research Support (); Arcutis Biotherapeutics, Inc.: Grant/Research Support (); B. Braun Medical Inc.: Grant/Research Support (); Basilea Pharmaceutica: Grant/Research Support (); Boston Pharmaceuticals: Grant/Research Support (); Celdara Medical LLC: Grant/Research Support (); Cidara Therapeutics Inc.: Grant/Research Support (); Cipla USA: Grant/Research Support (); Crestone Inc.: Grant/Research Support (); CXC: Grant/Research Support (); Debiopharm International SA: Grant/Research Support (); Entasis Therapeutics: Grant/Research Support (); Evopoint Biosciences Co.: Grant/Research Support (); Fedora Pharmaceuticals: Grant/Research Support (); GlaxoSmithKline: Grant/Research Support (); Hoffmann-La Roche: Grant/Research Support (); Insmed Inc.: Grant/Research Support (); Iterum Therapeutics Limited: Grant/Research Support (); Kaizen Bioscience, Co.: Grant/Research Support (); KBP Biosciences USA: Grant/Research Support (); Lassen Therapeutics: Grant/Research Support (); Matinas Biopharma: Grant/Research Support (); Meiji Seika Pharma Co., Ltd.: Grant/Research Support (); Melinta Therapeutics: Grant/Research Support (); Menarini Ricerche S.p.A.: Grant/Research Support (); Mutabilis: Grant/Research Support (); Nabriva Therapeutics AG: Grant/Research Support (); Novartis Pharmaceuticals Corp.: Grant/Research Support (); Paratek Pharmaceuticals, Inc.: Grant/Research Support (); PureTech Health: Grant/Research Support (); Sfunga Therapeutics: Grant/Research Support (); Spero Therapeutics: Grant/Research Support (); Suzhou Sinovent Pharmaceuticals Co.: Grant/Research Support (); TauRx Therapeutics: Grant/Research Support (); Tetraphase Pharmaceuticals: Grant/Research Support (); tranScrip Partners: Grant/Research Support (); Utility Therapeutics: Grant/Research Support (); Valanbio Therapeutics, Inc.: Grant/Research Support (); VenatoRx: Grant/Research Support (); Wockhardt Bio AG: Grant/Research Support ()
Sarah McLeod, PhD (she/her/hers)
Director
Entasis Therapeutics
Waltham, Massachusetts, United States
Disclosure: Disclosure(s): Entasis Therapeutics: Employee ()
Alita Miller, PhD
CSO
Entasis Therapeutics
Waltham, Massachusetts, United States
Disclosure: Disclosure(s): Entasis Therapeutics: Employee ()
Paul G. Ambrose, PharmD; MS; FIDSA
President
Institute for Clinical Pharmacodynamics
Schenectady, New York, United States
Disclosure: Disclosure(s): Adagio Therapeutics, Inc.: Grant/Research Support (); Amplyx Pharmaceuticals, Inc.: Grant/Research Support (); AN2 Therapeutics: Grant/Research Support (); Antabio SAS: Grant/Research Support (); Arcutis Biotherapeutics, Inc.: Grant/Research Support (); B. Braun Medical Inc.: Grant/Research Support (); Basilea Pharmaceutica: Grant/Research Support (); Boston Pharmaceuticals: Grant/Research Support (); Bravos Biosciences: Ownership Interest (); Celdara Medical LLC: Grant/Research Support (); Cidara Therapeutics Inc.: Grant/Research Support (); Cipla USA: Grant/Research Support (); Crestone Inc.: Grant/Research Support (); CXC: Grant/Research Support (); Debiopharm International SA: Grant/Research Support (); Entasis Therapeutics: Grant/Research Support (); Evopoint Biosciences Co.: Grant/Research Support (); Fedora Pharmaceuticals: Grant/Research Support (); GlaxoSmithKline: Grant/Research Support (); Hoffmann-La Roche: Grant/Research Support (); ICPD: Ownership Interest (); ICPD Biosciences, LLC.: Ownership Interest (); ICPD Holdings: Ownership Interest (); ICPD Technologies: Ownership Interest (); Insmed Inc.: Grant/Research Support (); Iterum Therapeutics Limited: Grant/Research Support (); Kaizen Bioscience, Co.: Grant/Research Support (); Matinas Biopharma: Grant/Research Support (); Meiji Seika Pharma Co., Ltd.: Grant/Research Support (); Melinta Therapeutics: Grant/Research Support (); Menarini Ricerche S.p.A.: Grant/Research Support (); Mutabilis: Grant/Research Support (); Nabriva Therapeutics AG: Grant/Research Support (); Novartis Pharmaceuticals Corp.: Grant/Research Support (); Paratek Pharmaceuticals, Inc.: Grant/Research Support (); PureTech Health: Grant/Research Support (); Sfunga Therapeutics: Grant/Research Support (); Spero Therapeutics: Grant/Research Support (); Suzhou Sinovent Pharmaceuticals Co.: Grant/Research Support (); TauRx Therapeutics: Grant/Research Support (); Tetraphase Pharmaceuticals: Grant/Research Support (); tranScrip Partners: Grant/Research Support (); Utility Therapeutics: Grant/Research Support (); Valanbio Therapeutics, Inc.: Grant/Research Support (); VenatoRx: Grant/Research Support (); Wockhardt Bio AG: Grant/Research Support ()
Ruben Tommasi, PhD
Entasis Therapeutics
Waltham, Massachusetts, United States
Disclosure: Disclosure(s): Entasis Therapeutics: Employee ()
John O'Donnell, B.S
Head of DMPK
Entasis Therapeutics
Waltham, Massachusetts, United States
Disclosure: Disclosure(s): Entasis Therapeutics: Employee ()